Therapeutic Workshop
Pain: "A Pain-Free Guide to Current Therapies"
Monday, February 11, 2008
9:30 AM
Louis XVI Suite Center/West
Pain is the most common reason patients seek medical attention. Studies suggest that 40% of U.S. adults experience pain daily, while 90% experience pain monthly. It is therefore no surprise that the worldwide pain management market is expected to reach over $30 billion. Pain comes in all shapes and sizes ? individuals suffer from acute and chronic pain, post-operative pain, sports-related injuries, neuropathy, migraines, arthritis, lower back pain, and fibromyalgia, among other conditions. Despite the prevalence of pain, clinically effective treatment options are limited. This panel will discuss recent efforts to develop drugs that confer greater efficacy and fewer side-effects.
Moderators
- Greg Wade, Ph.D.; Biotech Analyst, Pacific Growth Equities
Panelists
- Daniel Carr, M.D.; CEO, Javelin Pharmaceuticals, Inc.
- Ravi Anand, M.D.; Chief Medical Officer, Newron Pharmaceuticals S.p.A.
- Anthony DiTonno; President & CEO, NeurogesX, Inc.
- Alexis Borisy, A.M.; President and CEO, Founder, CombinatoRx, Inc.
- David C. Yeomans, Ph.D.; Director of Pain Research, Associate Professor Department of Anesthesia, Stanford University
Who's Who
Expert: